GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.15G262100	P00463	Methylpolysilicone	1	1.04675035065746e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P01398	Stizolobinate	1	9.38907282273593e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P01962	(2E,4Z)-4-hydroxy-6-oxohexa-2,4-dienoic acid	1	4.47835478632337e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P01976	Ser-Tyr	1	4.95939658249082e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P04074	(+)-Indocarbazostatin	1	2.93404875574115e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P04966	Dihydroxytryptamine	1	7.71512623044996e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P05800	Slaframine	1	3.1507034768607e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P06692	Isophorene	1	1.337231761814e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P07022	Melrosin A	1	8.15681448561821e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P09580	Diphenylphosphine	1	1.0984849271891e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P09738	Gelsemicine	1	2.27252425442207e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P10046		1	4.93719746992214e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P10935	Acorafloxacin	1	9.40122991923213e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P12323	Allamandicin	1	9.7146796966271e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P13495	DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)	1	5.06366278474328e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P14370	4-Tert-butyl-2-[(tert-butylamino)methyl]-6-(4-chlorophenyl)phenol	1	1.97436180584243e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P17358	alpha-Carboxyethyl hydroxychroman	1	2.61146512776315e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P18970	Deoxypumiloside	1	8.67499228041992e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P19004	5-Hydroxyketamine	1	2.23434387204068e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P21190		1	9.23281312043106e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P21212	Phenyllactylglucose	1	8.54786531058775e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P22489	L-Carnitinyl-CoA	1	1.26448726999302e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P24956	Crocinervolide	1	7.47764390168242e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P25683	alpha-Curcumene	1	4.90825350273165e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P25741	MG(0:0/5-iso PGF2VI/0:0)	1	1.27404706988185e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P25779	allo-Aromadendrane-10beta,14-diol	1	5.34562389218598e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P25891	Iryantherin F	1	4.90521507597722e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P26122	Isometamidium chloride	1	7.78480198893475e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P28189	LysoPS(18:2(9Z,12Z)/0:0)	1	2.57988879241156e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P28330	allo-Aromadendrane-10beta,14-diol	1	4.13524490682005e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P28402	CPA(18:1(11Z)/0:0)	1	8.39208441553822e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P28616		1	1.0871741575154e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P29878	16-Hydroxymilolide G	1	3.55874759949374e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P29880	Mukurozioside IIa	1	8.51623329606786e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P29881		1	2.44578987458811e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P30357	Cellulose triacetate	1	1.84428632795691e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P30445	4,10-dihydroxy-10-methylundecan-4-olide	1	2.63741036074008e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P30524	Indane	1	1.50917375856469e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P30547	Loratadine	1	1.9753169361652e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P30782	Cryptostigmin IV	1	8.41777762409235e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P30912		1	3.78193676167664e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P32066	Lucyoside J	1	6.25894407326287e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P32075	3-O-beta-D-Glucopyranosyl hederagenin	1	1.22167412842316e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P32646	Antibiotic DC 11A2	1	5.8128428650233e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P32954	Acanjaposide B	1	4.17948366526091e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P32974		1	1.54581890742928e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P34576		1	1.16842680831283e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P34836	Alloeremophilone	1	1.98011433789771e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P34871	3-O-beta-D-Glucopyranosyl hederagenin	1	4.24445163133132e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P35047	Goshonoside F3	1	6.0820519808228e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P35649	Antibiotic BU 3292TA	1	4.64180614665892e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P35973	Soyasaponin aa	1	5.7484329639623e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P35977	Unguisin A	1	2.39907857358334e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P36560	10-Hydroxy-cadin-4-en-3-one	1	8.20258838449225e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P36585	Crocinervolide	1	2.50360964801236e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P36912	Rhodojaponin IV	1	3.52565101281033e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37263		1	1.85721173503868e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37271	PGP(TXB2/i-15:0)	1	9.21731717209484e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37297	Citrumarin A	1	6.5163456030754e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37330	5,6-Epoxyoctadeca-7,9-diynoic acid	1	3.58577517792746e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37350	Nobiloside	1	3.60093419230735e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37352	16-{[6-O-acetyl-2-O-(6-O-acetyl-beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}hexadecanolide	1	6.98395870683495e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37394	Bryostatin 10	1	1.60251145981289e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P37528	6beta-(2'-Methylbutanoyloxy)-10beta-hydroxy-8alpha-methoxyeremophil-7(11)-en-12,8beta-olide	1	1.53657011142605e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P38064	Terizidone	1	5.3767543763586e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P38319	Ingenol 3-hexadecanoate	1	1.72675161789782e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P38351	Voacamine	1	2.6908742065766e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P38849	PIP(16:2(9Z,12Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))	1	1.33143648109446e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P39614	Asukamycin E	1	1.58532018354905e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P39989	Kahalalide V	1	2.81422223902855e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P40102	Ampeloside Bs1	1	5.07663629934721e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P41961	Officinalisin II	1	2.71384801019794e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P41997	Bisglaucumlide B	1	4.86423151924572e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42008		1	3.8974126674251e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42047		1	2.59703352814698e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42093		1	4.3330076836173e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42128		1	3.18883964084902e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42130	PIP(18:2(10E,12Z)+=O(9)/20:2(11Z,14Z))	1	6.24217611359156e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42141	TG(22:0/20:0/a-25:0)[rac]	1	8.38141535472658e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42320		1	3.85557916389656e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P42692		1	1.59509869576228e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P43340	Meehanine B	1	1.66733595837238e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P43361		1	9.78726002068816e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P43364		1	5.98089966309433e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P44467	Atorvastatin lactone	1	4.61292290770954e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P44481	1-dodecanoyl-2-tetradecanoyl-glycero-3-phospho-(1'-myo-inositol)	1	8.35183326001154e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P44713	Safranal	1	8.41115240178264e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P44967	Minwanensin	1	1.49697291288288e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P51146	Embutramide	1	3.67311710032111e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P51532	Embutramide	1	1.34560225811741e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G262100	P54063	(2E,4E)-Pentadeca-2,4-dienoylcarnitine	1	2.22440485635947e-11	overlap	1e-10	<	Wm82.a2.v1